GlassScriptPhysician profile
Brian Ceballos
NPI 1376178277
$56,704.75
in general payments reported to CMS, 2019-2025
11 companies · $53K in 2025
The $53K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $101 · 2023: $616 · 2024: $2,583 · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Food and Beverage: $4,680 · Travel and Lodging: $1,924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Food and Beverage | $4,679.53 |
| Travel and Lodging | $1,923.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $54,406.56 | 2023-2025 | General - Erectile Dysfunction, General - Therapies, Ams 700 |
| Coloplast Corp | $998.62 | 2025 | |
| Axonics, INC. | $369.28 | 2023-2024 | Axonics, Bulkamid |
| Endo USA, INC. | $239.98 | 2024-2025 | Xiaflex |
| Endo Pharmaceuticals INC. | $221.41 | 2022-2023 | Xiaflex |
| Urogen Pharma, INC. | $149.22 | 2025 | |
| Olympus America INC. | $135.14 | 2025 | Itind System |
| Laborie Medical Technologies Corp. | $99.90 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Bluewind Medical | $41.75 | 2024 | Revi |
| Davol INC. | $24.95 | 2025 | Arista |
| Antares Pharma, INC. | $17.94 | 2025 | Xyosted |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ceballos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.